Advanced Search

Home > Journals > Minerva Endocrinologica > Archive > Minerva Endocrinologica 2012 June;37(2) > Minerva Endocrinologica 2012 June;37(2):141-56

CURRENT ISSUE   ARCHIVE   EPUB AHEAD OF PRINT   MOST READ


MINERVA ENDOCRINOLOGICA

Minerva Endocrinologica 2012 June;37(2):141-56

 

    ENDOCRINE ONCOLOGY

Pheochromocytoma: implications in tumorigenesis and the actual management

Shah U., Giubellino A., Pacak K.

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA

Pheochromocytomas and paragangliomas are rare neuroendocrine catecholamine producing tumors with varied clinical presentations, biochemistries and genetic makeup. These features outline the complexity and the difficulties in studying and understanding the oncogenesis of these tumors. The study of families with genetically inherited mutations in pheochromocytoma susceptibility genes has greatly enhanced our understanding of the pathophysiology and mechanisms of oncogenesis of the disease, and consequently changed our clinical approach. Several molecular pathways and mutations in their important regulatory proteins have been identified. Such mutations are responsible for the dysregulation of metabolic pathways involved in oxygen and nutrient sensing, apoptosis regulation, cell proliferation, migration and invasion. The knowledge derived from the study of these pathways will be fundamental in the future clinical management of these patients. As a rare disease that often masks its clinical presentation, the diagnosis is frequently missed and a high level of suspicion is required. Management of this disease requires a multidisciplinary team approach and will be discussed along with advances in its treatment.

language: English


FULL TEXT  REPRINTS

top of page